Primary dose reduction (PDR) of chemotherapy (chemo) in patients (Pts) older than age 65 with advanced cancer (Ca) and toxicity outcomes.
Ajeet Gajra(Pinnacle Clinical Research), Arti Hurria(Unknown), Heidi D. Klepin(Wake Forest University), Reena Jayani(Vanderbilt University Medical Center), Supriya G. Mohile(University of Rochester Medical Center), Katherine Hansen, Kayo Togawa, William P. Tew(Memorial Sloan Kettering Cancer Center), Stuart M. Lichtman(Memorial Sloan Kettering Cancer Center), S. Klapper, Vani Katheria(City of Hope), CP Gross, Rupal Ramani, Molly Hardt, Jean Brown, Cynthia Owusu
Cited by 1
Related Papers
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
|Journal of Clinical Oncology|2011|1.8k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|Journal of Clinical Oncology|2015|1k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|CA A Cancer Journal for Clinicians|2015|737